Marktanalyse - Digestive Remedies in Belgium

The main event in 2011 was the sudden questioning of Janssen-Cilag’s Motilium, the leading brand in digestive remedies. According to research by Luc Hondeghem, a Belgian pharmacologist, domperidon, the molecule of Motilium could kill hundreds of people every year with a sudden heart attack. While the US never accepted this product (even in the Rx market), Motilium became the leading local brand in Belgium and the leader if international analgesic blockbusters Dafalgan and Nurofen are excluded.

Euromonitor International's Digestive Remedies in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

DIGESTIVE REMEDIES IN BELGIUM

Euromonitor International

June 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Digestive Remedies by Category: Value 2006-2011

Table 2 Sales of Digestive Remedies by Category: % Value Growth 2006-2011

Table 3 Digestive Remedies Company Shares by Value 2007-2011

Table 4 Digestive Remedies Brand Shares by Value 2008-2011

Table 5 Forecast Sales of Digestive Remedies by Category: Value 2011-2016

Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Laboratoria Qualiphar NV SA in Consumer Health (belgium)

Strategic Direction

Key Facts

Summary 1 Qualiphar NV SA, Laboratoria: Key Facts

Summary 2 Qualiphar NV SA, Laboratoria: Operational Indicators

Company Background and Production

Competitive Positioning

Summary 3 Qualiphar NV SA, Laboratoria: Competitive Position 2011

Tilman NV SA in Consumer Health (belgium)

Strategic Direction

Key Facts

Summary 4 Tilman NV SA: Key Facts

Summary 5 Tilman NV SA: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 6 Tilman NV SA: Competitive Position 2011

Executive Summary

Slight But Fragile Recovery in 2011

Negative Environment for Consumer Health Affects Sales

Disparate Results in A Still Fragmented Competitive Environment

Distribution Remains Under the Control of Pharmacies Despite Some Changes

Bleak Prospects Overall

Key Trends and Developments

Fragile Economic Recovery To Result in A Temporary Improvement

Authorities and Medical Experts Blow Hot and Cold

More Health & Wellness, Certainly, But Also More Realism

Remedies for Increasingly Stressful Lifestyles

Brand Equity To Remain the Key in A Restricted Environment

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 8 Life Expectancy at Birth 2006-2011

Market Data

Table 9 Sales of Consumer Health by Category: Value 2006-2011

Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 11 Consumer Health Company Shares 2007-2011

Table 12 Consumer Health Brand Shares 2008-2011

Table 13 Penetration of Private Label by Category 2006-2011

Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011

Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements - Registration and Classification

Switch Climate

Self-medication and Preventative Medicine

Generics

Switches

Summary 7 OTC - Switches 2009-2011

Sources

Summary 8 Research Sources

• Digestive Remedies in Azerbaijan
• Digestive Remedies in Chile
• Digestive Remedies in China
• Digestive Remedies in Poland
• Diverticulitis Global Clinical Trials Review, H1, 2013
• Inflammatory Bowel Disease – Pipeline Review, H1 2013
• Liver Fibrosis – Pipeline Review, H1 2013
• Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) – Pipeline Review, H1 2013
• Alopecia – Pipeline Review, H1 2013
• Amyloidosis – Pipeline Review, H1 2013
• Appendicitis Global Clinical Trials Review, H1, 2013
• Cholangitis Global Clinical Trials Review, H1, 2013
• Cholecystitis Global Clinical Trials Review, H1, 2013
• Cholestasis Global Clinical Trials Review, H1, 2013
• Cirrhosis – Pipeline Review, H1 2013
• Constipation Global Clinical Trials Review, H1, 2013
• Diarrhea Global Clinical Trials Review, H1, 2013
• Digestive Remedies in Australia
• Digestive Remedies in Croatia
• Digestive Remedies in Uruguay